1. Home
  2. CGEM vs ALLT Comparison

CGEM vs ALLT Comparison

Compare CGEM & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ALLT
  • Stock Information
  • Founded
  • CGEM 2016
  • ALLT 1996
  • Country
  • CGEM United States
  • ALLT Israel
  • Employees
  • CGEM N/A
  • ALLT N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ALLT Telecommunications Equipment
  • Sector
  • CGEM Health Care
  • ALLT Telecommunications
  • Exchange
  • CGEM Nasdaq
  • ALLT Nasdaq
  • Market Cap
  • CGEM 366.3M
  • ALLT 342.5M
  • IPO Year
  • CGEM 2021
  • ALLT 2006
  • Fundamental
  • Price
  • CGEM $5.95
  • ALLT $10.85
  • Analyst Decision
  • CGEM Strong Buy
  • ALLT Buy
  • Analyst Count
  • CGEM 7
  • ALLT 1
  • Target Price
  • CGEM $26.00
  • ALLT N/A
  • AVG Volume (30 Days)
  • CGEM 789.8K
  • ALLT 489.2K
  • Earning Date
  • CGEM 11-06-2025
  • ALLT 11-18-2025
  • Dividend Yield
  • CGEM N/A
  • ALLT N/A
  • EPS Growth
  • CGEM N/A
  • ALLT N/A
  • EPS
  • CGEM N/A
  • ALLT N/A
  • Revenue
  • CGEM N/A
  • ALLT $95,342,000.00
  • Revenue This Year
  • CGEM N/A
  • ALLT $10.64
  • Revenue Next Year
  • CGEM N/A
  • ALLT $15.76
  • P/E Ratio
  • CGEM N/A
  • ALLT N/A
  • Revenue Growth
  • CGEM N/A
  • ALLT 4.74
  • 52 Week Low
  • CGEM $5.68
  • ALLT $2.78
  • 52 Week High
  • CGEM $17.98
  • ALLT $11.42
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 39.45
  • ALLT 66.22
  • Support Level
  • CGEM $5.68
  • ALLT $9.55
  • Resistance Level
  • CGEM $6.13
  • ALLT $11.41
  • Average True Range (ATR)
  • CGEM 0.29
  • ALLT 0.52
  • MACD
  • CGEM 0.03
  • ALLT 0.07
  • Stochastic Oscillator
  • CGEM 28.42
  • ALLT 74.02

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

Share on Social Networks: